Characterization of the novel chemically modified fungal polysaccharides as the macrophage stimulators

International Immunopharmacology

Volumn 9, Issue 6, 2009, Pages 729-733

  Dergunova, Marina A ^a   Alexeenko, Tatyana V ^a   Zhanaeva, Svetlana Ya ^a   Filyushina, Elena E ^a   Buzueva, Irina I ^a   Kolesnikova, Olga P ^b   Kogan, Grigorij ^c   Korolenko, Tatyana A ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b INSTITUTE OF CLINICAL IMMUNOLOGY   (Russian Federation)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Chitin glucan; Glucan; Liver macrophages; Lysosomal enzymes; Polysaccharides

Indexed keywords

CARBOXYMETHYLATED GLUCAN; CARBOXYMETHYLCHITIN GLUCAN; CHITOTRIOSIDASE; GLUCAN; IMMUNOSTIMULATING AGENT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPERGILLUS NIGER; BONE MARROW BIOPSY; CONTROLLED STUDY; IMMUNOSTIMULATION; LIVER HOMOGENATE; LYSOSOME; MACROPHAGE ACTIVATION; MALE; METHYLATION; MOUSE; MYCELIUM; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ACID PHOSPHATASE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ASPERGILLUS NIGER; BONE MARROW; CHITIN; GLUCANS; HEXOSAMINIDASES; LYSOSOMES; MACROPHAGES; MALE; MICE; MICE, INBRED CBA; PHAGOCYTOSIS; SACCHAROMYCES CEREVISIAE;

EID: 67349253444     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.02.009     Document Type: Article

References (51)

1. Tzianabos A.O. Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13 (2000) 523-533
2. Bohn J.A., and BeMiller J.N. (1 → 3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr Polym 28 (1995) 3-14
3. Williams D.L. Overview of (1 → 3)-β-d-glucan immunobiology. Mediators Inflamm 6 (1997) 247-250
4. Kogan G. (1 → 3,1 → 6)-β-D-Glucans of yeasts and fungi and their biological activity. In: Atta-ur-Rahman (Ed). Studies in natural products chemistry. Bioactive Natural Products (Part D) vol. 23 (2000), Elsevier, Amsterdam 107-152
5. Amati L., Leogrande D., Passeri M.E., Mastronardi M.L., Passantino L., Venezia P., et al. β- Glucans: old molecules with newly discovered immunological activities. Drug Des Rev Online 2 (2005) 251-258
6. Novak M., and Vetvicka V. Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. J Immunotoxicol 5 (2008) 47-57
7. Bartnicki-Garcia S. Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22 (1968) 87-108
8. Farkaš V. Biosynthesis of cell walls of fungi. Microbiol Rev 43 (1979) 117-144
9. Williams D.L., Mueller A., and Browder W. Glucan-based macrophage stimulators. A review of their anti-infective potential. Clin Immunother 5 (1996) 392-399
10. Browder W., Williams D., Pretus H., Olivero G., Enrichens F., Mao P., et al. Beneficial effect of enhanced macrophage function in trauma patient. Ann Surg 211 (1990) 605-613
11. Kidd P.M. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5 (2000) 4-27
12. Hashimoto T., Ohno N., Adachi Y., and Yadomae T. Enhanced production of inducible nitric oxide synthase by beta-glucans in mice. FEMS Immunol Med Microbiol 19 (1997) 131-135
13. Ross G.D., Vetvicka V., Yan J., Xia Y., and Vetvickova J. Therapeutic intervention with comlement and β-glucan in cancer. Immunopharmacology 42 (1999) 61-74
14. Kokoshis P.L., Williams D.L., Cook D.L., and DiLuzio N.R. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by β-glucan. Science 199 (1978) 1340-1342
15. Ljungman A.G., Leanderson P., and Tagesson C. (1 → 3)-β-d-Glucan stimulates nitric oxide generation and cytokine mRNA expression in macrophages. Environ Toxicol Pharmacol 5 (1998) 273-281
16. Cross G.G., Jennings H.J., Whitfield D.M., Penney C.L., Zacharie B., and Gagnon L. Immunostimulant oxidized β-glucan conjugates. Int Immunopharmacol 1 (2001) 539-550
17. Morikawa K., Takeda R., Yamazaki M., and Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by linear β-1,3-d-glucan and other immunomodulators in murine cells. 14. Cancer Res 45 (1985) 1496-1501
18. Engstad C.S., Engstad E.E., Olsen J.-O., and Østerud B. The effect of soluble β-1,3-glucan and lipopolysaccharide on cytokine production and coagulation activation in whole blood. Int Immunopharmacol 2 (2002) 1585-1597
19. Vetvicka V., and Yvin J.-C. Effects of marine β-1,3 glucan on immune reactions. Int Immunopharmacol 4 (2004) 721-730
20. Ross G.D., Cain J.A., Myones B.L., Newman S.L., and Lachmann P.J. Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement 4 (1987) 61-74
21. Zimmerman J.W., Lindermuth J., Fish P.A., Palace G.P., Stevenson T.T., and DeMong D.E. A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J Biol Chem 273 (1998) 22014-22020
22. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., et al. Human monocyte scavenger receptors are pattern recognition receptors for (1 → 3)-β-d-glucans. J Leukoc Biol 72 (2002) 140-146
23. Brown G.D., and Gordon S. Immune recognition: a new receptor for beta-glucans. Nature 413 (2001) 36-37
24. Williams D.L., McNamee R.B., Jones E.L., Pretus H.A., Ensley H.E., and Browder I.W. A method for the solubilization of a (1 → 3)-β-d-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 219 (1991) 203-213
25. Kogan G., Staško A., Bauerová K., Polovka M., Šoltés L., and Brezová V. Antioxidant properties of yeast (1 → 3)-β-d-glucan studied by Electron Paramagnetic Resonance spectroscopy and its activity in the adjuvant arthritis. Carbohydr Polym 61 (2005) 18-28
26. Slameňová D., Lábaj J., Križková L., Kogan G., Šandula J., and Bresgen N. Protective effects of fungal (1 → 3)-β-d-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells. Cancer Lett 198 (2003) 153-160
27. Miadoková E., Svidová S., Vlčková V., Kogan G., and Rauko P. The role of microbial polysaccharides in cancer prevention and therapy. J Cancer Integr Med 2 (2004) 173-178
28. Kogan G., Šandula J., Korolenko T.A., Falameeva O.V., Poteryaeva O.N., Zhanaeva S.Y.a., et al. Increased efficiency of Lewis lung carcinoma chemotherapy with a macrophage stimulator-yeast carboxymethyl glucan. Int Immunopharmacol 2 (2002) 775-781
29. Khalikova T.A., Zhanaeva S.Y.a., Korolenko T.A., Kaledin V.I., and Kogan G. Regulation of activity of cathepsins B, L, and D in murine lymphosarcoma model at a combined treatment with cyclophosphamide and yeast polysaccharide. Cancer Lett 223 (2005) 77-83
30. Machová E., Kogan G., Chorvatovičová D., and Šandula J. Ultrasonic depolymerization of the chitin-glucan complex from Aspergillus niger and antimutagenic activity of its product. Ultrason Sonochem 5 (1999) 111-114
31. Kogan G., Rauko P., and Machová E. Fungal chitin-glucan derivatives exert protective or damaging activity on plasmid DNA. Carbohydr Res 338 (2003) 931-935
32. 13C-NMR spectroscopic investigation of two yeast cell wall β-D-glucans. Biopolymers 27 (1988) 1055-1063
33. Machová E., Kogan G., Alföldi J., Šoltés L., and Šandula J. Enzymatic and ultrasonic depolymerization of carboxymethylated β-1,3-d-glucan derived from Saccharomyces cerevisiae. J Appl Polym Sci 55 (1995) 699-704
34. Machová E., Kogan G., Šoltés L., Kvapilová K., and Šandula J. Ultrasonic depolymerization of the chitin-glucan isolated from Aspergillus niger. React Funct Polym 42 (1999) 265-271
35. Stiffel C., Mouton D., and Biozzi G. Role of the macrophages in nonspecific immunity. Ann Inst Pasteur 120 (1971) 412-427
36. McDowell H.P., Donfrancesco A., Milano G.M., Clerico A., Mannarino O., and Altavista P. Detection and clinical significance of disseminated tumor cells at diagnosis in bone marrow of children with localized rhabdomyosarcoma. Eur J Cancer 41 (2005) 2288-2296
37. Hardonk M.J., Dijkhuis F.W.J., Hulstaert C.E., and Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 52 (1992) 296-302
38. Gifford G.E., and Flick D.A. Natural production and release of tumour necrosis factor. Ciba Found Symp 131 (1987) 3-20
39. Barrett A.J. Lysosomal enzymes. In: Dingle J.T. (Ed). Lysosomes: a laboratory handbook (1972), North-Holland Pub. Co., Amsterdam, London 46-135
40. Dergunova M.A., Filushina E.E., Buzueva I.I., Filatova T.G., Korolenko T.A., Makarova O.P., et al. Study of chemically modified polysaccharide chitocarboxymethylglucan as a new macrophage stimulator. Bull SO RAMN 3-4 (2000) 58-61
41. Borchers A.T., Keen C.L., and Gershwin M.E. Mushrooms, tumors, and immunity: an update. Exp Biol Med 229 (2004) 393-406
42. Lukina E.A. A system of mononuclear phagocytes and the biological effects of pro-inflammatory cytokines (in Russian). Russ J Gastroenterol Hepatol Coloproctol 5 (1999) 7-13
43. Sherwood E.R., Williams D.L., McNamee R.B., Jones E.L., Browder I.W., and DiLuzio N.R. In vitro tumoricidal activity of resting and glucan-activated Kupffer cells. J Leukoc Biol 42 (1987) 69-75
44. Berthiaume E.P., Medina C., and Swanson J.A. Molecular size-fractionation during endocytosis in macrophages. J Cell Biol 129 (1995) 989-998
45. Miura T., Ohno N., Miura N.N., Adachi Y., Shimada S., and Yadomae T. Antigen-specific response of murine immune system toward a yeast β-glucan preparation, zymosan. FEMS Immunol Med Microbiol 24 (1999) 131-139
46. Majtán J., Kogan G., Kováčová E., Bíliková K., and Šimúth J. Stimulation of TNF-α release by fungal cell wall polysaccharides. Z Naturforsch 60c (2005) 921-926
47. Vetvicka V., Volny T., Saraswat-Ohri S., Vashishta A., Vancikova Z., and Vetvickova J. Glucan and resveratrol complex-possible synergistic effects on immune system. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 151 (2007) 41-46
48. Vetvicka V., and Vetvickova J. Physiological effects of different types of beta-glucan. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 151 (2007) 225-231
49. Vetvicka V., Vashishta A., Saraswat-Ohri S., and Vetvickova J. Immunological effects of yeast- and mushroom-derived beta-glucans. J Med Food 11 (2008) 615-622
50. Vetvicka V., Vetvickova J., Frank J., and Yvin J.C. Enhancing effects of new biological response modifier beta-1,3 glucan sulphate PS3 on immune reactions. Biomed Pharmacother 62 (2008) 283-288
51. Korolenko T.A., Dergunova M.A., Alekseenko T.V., Zhanaeva S.Y., Filyushina E.E., and Filatova T.G. Intralysosomal accumulation of gadolinium and lysosomal damage during selective depression of liver macrophages in vivo. Bull Exp Biol Med 142 (2006) 391-394